Emergence of IMP-4 metallo-β-lactamase in a clinical isolate from Australia
Open Access
- 1 September 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 54 (3) , 699-700
- https://doi.org/10.1093/jac/dkh398
Abstract
1Infectious Diseases and Microbiology Unit, The Alfred Hospital, Melbourne, 3181; 2Microbiology and Infectious Diseases Department, Women's and Children's HospiKeywords
This publication has 6 references indexed in Scilit:
- Epidemiology of Rifampin ADP-Ribosyltransferase ( arr-2 ) and Metallo-β-Lactamase ( bla IMP-4 ) Gene Cassettes in Class 1 Integrons in Acinetobacter Strains Isolated from Blood Cultures in 1997 to 2000Antimicrobial Agents and Chemotherapy, 2003
- Emerging carbapenemases in Gram-negative aerobesClinical Microbiology & Infection, 2002
- Nosocomial Outbreak of Carbapenem-Resistant Pseudomonas aeruginosa with a New bla IMP Allele, bla IMP-7Antimicrobial Agents and Chemotherapy, 2002
- Metallo-β-Lactamases in Clinical Pseudomonas Isolates in Taiwan and Identification of VIM-3, a Novel Variant of the VIM-2 EnzymeAntimicrobial Agents and Chemotherapy, 2001
- IMP-4, a Novel Metallo-β-Lactamase from Nosocomial Acinetobacter spp. Collected in Hong Kong between 1994 and 1998Antimicrobial Agents and Chemotherapy, 2001
- Occurrence of a new metallo-β-lactamase IMP-4 carried on a conjugative plasmid in Citrobacter youngae from the People's Republic of ChinaFEMS Microbiology Letters, 2001